Pharmacy Technician Certification Board Practice Exam Practice Question

Correct Answer: B

Rationale: Desvenlafaxine is primarily indicated for the treatment of major depressive disorder (MDD), as it is a serotonin-norepinephrine reuptake inhibitor (SNRI) that effectively alleviates depressive symptoms.

Option A, hypertension, is incorrect; while Desvenlafaxine can affect blood pressure, it is not approved for hypertension treatment. Option C, benign prostatic hypertrophy, is unrelated to Desvenlafaxine's mechanism or indications. Finally, option D, atrial fibrillation, pertains to cardiac conditions, which Desvenlafaxine does not address. Thus, the focus on MDD confirms the appropriate use of this medication.